Mir-144-3p targeting ABCA1, the doorkeeper of RCT, resulted in impaired cholesterol efflux and boosted inflammatory response, which effectively accelerated the occurrence and progression of atherosclerosis in apoE−/− mice fed HFD. Here, ABCA1 is linked to atherosclerosis.